Abstract

BackgroundColon carcinoma is one of the commonly tumors that threaten human beings as its highly morbidity and mortality. Recent evidences suggested that microRNA-21 (miR-21) played an important role in the development of colon carcinoma and might be a potential biological marker for the diagnosis and prognosis of colon carcinoma. However, the potential effect of miR-21 based therapeutic studies in colon carcinoma remains to be fully elucidated.MethodsIn present study, we constructed an eukaryotic expression vector encoding antisense oligonucleotides against miR-21 (termed as p-miR-21-ASO) and the expression of miRNA-21 in human colon cancer was detected by Real-time PCR. To assess its possible effect on the proliferation and migration capacity of human colon carcinoma cells in vitro, CCK-8 assay, colony formation assay and cell invasion, as well as migration assay, were performed respectively. Moreover, PTEN, one of target molecules of miRNA-21, was analyzed by Western blot and Fluorescence activated cell sorter assay. Finally, the transduction of AKT and ERK pathways in human colon carcinoma cells was determined by Western blot.ResultsWe found that transiently transfection of p-miR-21-ASO could efficiently decrease the relative expression of miR-21 in human colon carcinoma HCT116 cells, accompanied by impaired proliferation and clone formation. Furthermore, we found that down-regulation of miR-21 also could significantly abrogate the invasion and migration capacity in vitro, as well as the expression of vascular endothelial growth factor which is critical for the metastatic capacity of colon carcinoma cells. Mechanistic evidence showed that down-regulation of miR-21 increased the expression of its target molecule PTEN in HCT116 cells. Finally, we revealed that the expression level of both phosphor-ERK1/2 and phosphor-AKT also were altered.ConclusionsTherefore, our data suggested miR-21 ASO against miR-21 might be a useful strategy to alter the expression of miR-21 in colon carcinoma cells, which was helpful for the development of miR-21-based therapeutic strategies against clinical colon carcinoma.Electronic supplementary materialThe online version of this article (doi:10.1186/s12935-015-0228-7) contains supplementary material, which is available to authorized users.

Highlights

  • Colon carcinoma is one of the commonly tumors that threaten human beings as its highly morbidity and mortality

  • MiRNA‐21 Antisense oligonucleotides (ASO) reduced the colony formation capacity of human colon carcinoma cells we further investigate the possible effect of miR-21 ASO on the colony formation capacity of human colon carcinoma cells, which was closely related to the growth of cancer cells

  • MiRNA‐21 ASO reduced the proliferation of human colon carcinoma cells To investigate the possible effect of miR-21-based therapeutic strategy against human colon carcinoma cells, we

Read more

Summary

Introduction

Colon carcinoma is one of the commonly tumors that threaten human beings as its highly morbidity and mortality. Recent evidences suggested that microRNA-21 (miR-21) played an important role in the development of colon carcinoma and might be a potential biological marker for the diagnosis and prognosis of colon carcinoma. Recent evidences suggested that miR-21 as an oncomiRNA molecule played an important regulator role in the development of colon carcinoma including the proliferation, invasion and metastatic potential of cancer cells. Li et al showed that miRNA-21 might be a useful biological marker which was closely related to the diagnosis and prognosis of colon carcinoma [7]. These researches indicated the important role of miR-21 in the development and the diagnosis, as well as prognosis of colon carcinoma. Whether miR-21 may be used as a potential target in the biological therapy against colon carcinoma remains to be further elucidated

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.